IONS vs SLB · rev $514.0M vs P/E 12, rev $8.97B
Ionis Pharmaceuticals Inc (IONS) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported SLB revenue for 2026-06-30 was $8.97B. Net income was $786.0M. Revenue was up 2.9% from 2026-03-31 to 2026-06-30. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
IONS currently screens at market cap $12.28B. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the IONS and SLB stock pages for the full models.
Not investment advice.